Long-term air pollution exposure is associated with increased severity of rhinitis in 2 European cohorts.


Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
03 2020
Historique:
received: 15 05 2019
revised: 24 11 2019
accepted: 27 11 2019
pubmed: 28 1 2020
medline: 1 12 2020
entrez: 28 1 2020
Statut: ppublish

Résumé

Very few studies have examined the association between long-term outdoor air pollution and rhinitis severity in adults. We sought to assess the cross-sectional association between individual long-term exposure to air pollution and severity of rhinitis. Participants with rhinitis from 2 multicenter European cohorts (Epidemiological Study on the Genetics and Environment on Asthma and the European Community Respiratory Health Survey) were included. Annual exposure to NO A total of 1408 adults with rhinitis (mean age, 52 years; 46% men, 81% from the European Community Respiratory Health Survey) were included. The median (1st quartile-3rd quartile) score of rhinitis severity was 4 (2-6). Higher exposure to PM

Sections du résumé

BACKGROUND
Very few studies have examined the association between long-term outdoor air pollution and rhinitis severity in adults.
OBJECTIVE
We sought to assess the cross-sectional association between individual long-term exposure to air pollution and severity of rhinitis.
METHODS
Participants with rhinitis from 2 multicenter European cohorts (Epidemiological Study on the Genetics and Environment on Asthma and the European Community Respiratory Health Survey) were included. Annual exposure to NO
RESULTS
A total of 1408 adults with rhinitis (mean age, 52 years; 46% men, 81% from the European Community Respiratory Health Survey) were included. The median (1st quartile-3rd quartile) score of rhinitis severity was 4 (2-6). Higher exposure to PM

Identifiants

pubmed: 31983528
pii: S0091-6749(19)31636-7
doi: 10.1016/j.jaci.2019.11.040
pii:
doi:

Substances chimiques

Particulate Matter 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

834-842.e6

Subventions

Organisme : Medical Research Council
ID : G0901214
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : 92091
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Emilie Burte (E)

INSERM, U1168, VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France; University of Versailles St-Quentin-en-Yvelines, UMR 1168, Montigny le Bretonneux, France; ISGLobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Bénédicte Leynaert (B)

Inserm, UMR 1152, Pathophysiology and Epidemiology of Respiratory Diseases, Paris, France.

Alessandro Marcon (A)

Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Jean Bousquet (J)

INSERM, U1168, VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France; University of Versailles St-Quentin-en-Yvelines, UMR 1168, Montigny le Bretonneux, France; University Hospital, Montpellier, France; MACVIA-France, Contre les MAladies Chroniques pour un Vieillissement Actif en France, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.

Meriem Benmerad (M)

Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Inserm U1209, CNRS, University Grenoble Alpes, Institute for Advanced Biosciences (IAB), Grenoble, France.

Roberto Bono (R)

Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Anne-Elie Carsin (AE)

ISGLobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Kees de Hoogh (K)

Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.

Bertil Forsberg (B)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Frederic Gormand (F)

CHU de Lyon, Pneumology Department, Lyon, France.

Joachim Heinrich (J)

Ludwig Maximilians University Munich, University Hospital Munich, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Munich, Germany; Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, Munich, Germany.

Jocelyne Just (J)

Allergology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Armand-Trousseau, Paris, France; Sorbonne Université Paris 6, Paris, France.

Mark Nieuwenhuijsen (M)

ISGLobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Isabelle Pin (I)

Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Inserm U1209, CNRS, University Grenoble Alpes, Institute for Advanced Biosciences (IAB), Grenoble, France; Pediatrie, CHU de Grenoble Alpes, Grenoble, France.

Morgane Stempfelet (M)

Santé Publique France, Saint-Maurice, France.

Jordi Sunyer (J)

ISGLobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Simona Villani (S)

Unit of Biostatistics and Clinical Epidemiology, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Nino Künzli (N)

Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.

Valérie Siroux (V)

Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Inserm U1209, CNRS, University Grenoble Alpes, Institute for Advanced Biosciences (IAB), Grenoble, France.

Deborah Jarvis (D)

National Heart and Lung Institute, Imperial College London, London, United Kingdom; MRC Centre for Environment and Health, School of Public Health, London, United Kingdom.

Rachel Nadif (R)

INSERM, U1168, VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France; University of Versailles St-Quentin-en-Yvelines, UMR 1168, Montigny le Bretonneux, France.

Bénédicte Jacquemin (B)

INSERM, U1168, VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France; University of Versailles St-Quentin-en-Yvelines, UMR 1168, Montigny le Bretonneux, France; ISGLobal, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain. Electronic address: benedicte.jacquemin@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH